Elevance Health Inc.ANTMNYSE
LOADING
|||
| Metric | Q2 2022 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +14.12% | +77.83% | +33.65% | +30.66% | +31.27% |
| Gross Profit Growth | +14.12% | +22.70% | +20.03% | +16.77% | +17.34% |
| EBITDA Growth | -17.66% | -44.30% | +1869.80% | +1263.94% | -21.22% |
| Operating Income Growth | -7.69% | +5831.62% | +2295.04% | +1456.41% | +1601.74% |
| Net Income Growth | -7.98% | -7.16% | +94.13% | -2.84% | -28.06% |
| EPS Growth | -6.41% | +10.65% | +107.31% | +4.03% | -22.45% |
| EPS Diluted Growth | -6.48% | +13.87% | +109.83% | +5.18% | -21.53% |
| Weighted Average Shares Growth | -1.55% | -100.00% | -100.00% | -100.00% | -100.00% |
| Weighted Average Shares Diluted Growth | -1.62% | -100.00% | -100.00% | -100.00% | -100.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +45.69% | -134.23% | -39.17% | -19.17% | -53.71% |
| Free Cash Flow Growth | +54.29% | -154.50% | -38.36% | -21.86% | -64.07% |
| Receivables Growth | +11.95% | -13.64% | -12.04% | -13.65% | +57.38% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +4.92% | +19.20% | +22.84% | +21.42% | +21.75% |
| Book Value per Share Growth | +4.03% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +1.49% | -91.16% | -91.78% | -91.37% | -96.06% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +11.72% | +225.19% | -100.00% | -100.00% | -100.00% |